BackSonnet BioTherapeutics Holdings Overview

Sonnet BioTherapeutics Holdings Current Cash

Latest current cash for SONN: $5.1M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$5.12M
↑ 3325.93% YoYΔ $4.97M vs prior year quarter

Peer average

Loading

Sonnet BioTherapeutics Holdings Current Cash History

Loading

Sonnet BioTherapeutics Holdings vs. peers: Current Cash Comparison

Loading

Sonnet BioTherapeutics Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sonnet BioTherapeutics Holdings (SONN) FAQ

As of the most recent data (September 2025), SONN shows a current cash of $5.1M. That compares with $150K in the prior-year period — up 3325.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SONN's current cash is now $5.1M (was $150K) — a 3325.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sonnet BioTherapeutics Holdings is outperforming or lagging.

Tracking SONN's current cash over time shows whether Sonnet BioTherapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $5.1M That compares with $150K in the prior-year period — up 3325.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Sonnet BioTherapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $5.1M) with ownership activity and broader fundamentals.

Sonnet BioTherapeutics Holdings's current cash is $5.1M; compare it with other Consumer Staples names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.